 | • レポートコード：MRC2-11QY11229 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがん悪液質のグローバル市場について調査・分析したレポートです。種類別（プロゲストゲン、コルチコステロイド、併用療法）市場規模、用途別（病院店、小売薬局店、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がん悪液質の競争状況、市場シェア ・世界のがん悪液質市場：種類別市場規模 2015年-2020年（プロゲストゲン、コルチコステロイド、併用療法） ・世界のがん悪液質市場：種類別市場規模予測 2021年-2026年（プロゲストゲン、コルチコステロイド、併用療法） ・世界のがん悪液質市場：用途別市場規模 2015年-2020年（病院店、小売薬局店、オンライン薬局） ・世界のがん悪液質市場：用途別市場規模予測 2021年-2026年（病院店、小売薬局店、オンライン薬局） ・北米のがん悪液質市場分析：米国、カナダ ・ヨーロッパのがん悪液質市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがん悪液質市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがん悪液質市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがん悪液質市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aeterna Zentaris、Alder BioPharmaceuticals、Aphios、Eli Lilly、GTx、Helsinn、Merck、Novartis、Bristol-Myers Squibb、XBiotech ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
Market Analysis and Insights: Global Cancer Cachexia Market
The global Cancer Cachexia market size is projected to reach US$ 1663.4 million by 2026, from US$ 1591 million in 2020, at a CAGR of 4.2%% during 2021-2026.
Global Cancer Cachexia Scope and Market Size
Cancer Cachexia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Cachexia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Aeterna Zentaris
Alder BioPharmaceuticals
Aphios
Eli Lilly
GTx
Helsinn
Merck
Novartis
Bristol-Myers Squibb
XBiotech
Market segment by Type, the product can be split into
Progestogens
Corticosteroids
Combination therapies
Market segment by Application, split into
Hospital Stores
Retails Pharmacy Store
Online Pharmacy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Cachexia Revenue
1.4 Market by Type
1.4.1 Global Cancer Cachexia Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Progestogens
1.4.3 Corticosteroids
1.4.4 Combination therapies
1.5 Market by Application
1.5.1 Global Cancer Cachexia Market Share by Application: 2020 VS 2026
1.5.2 Hospital Stores
1.5.3 Retails Pharmacy Store
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cancer Cachexia Market Perspective (2015-2026)
2.2 Global Cancer Cachexia Growth Trends by Regions
2.2.1 Cancer Cachexia Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Cachexia Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Cachexia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Cachexia Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Cachexia Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Cachexia Players by Market Size
3.1.1 Global Top Cancer Cachexia Players by Revenue (2015-2020)
3.1.2 Global Cancer Cachexia Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Cachexia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Cachexia Market Concentration Ratio
3.2.1 Global Cancer Cachexia Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Cachexia Revenue in 2019
3.3 Cancer Cachexia Key Players Head office and Area Served
3.4 Key Players Cancer Cachexia Product Solution and Service
3.5 Date of Enter into Cancer Cachexia Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Cachexia Historic Market Size by Type (2015-2020)
4.2 Global Cancer Cachexia Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cancer Cachexia Market Size by Application (2015-2020)
5.2 Global Cancer Cachexia Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Cachexia Market Size (2015-2020)
6.2 Cancer Cachexia Key Players in North America (2019-2020)
6.3 North America Cancer Cachexia Market Size by Type (2015-2020)
6.4 North America Cancer Cachexia Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Cachexia Market Size (2015-2020)
7.2 Cancer Cachexia Key Players in Europe (2019-2020)
7.3 Europe Cancer Cachexia Market Size by Type (2015-2020)
7.4 Europe Cancer Cachexia Market Size by Application (2015-2020)
8 China
8.1 China Cancer Cachexia Market Size (2015-2020)
8.2 Cancer Cachexia Key Players in China (2019-2020)
8.3 China Cancer Cachexia Market Size by Type (2015-2020)
8.4 China Cancer Cachexia Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Cachexia Market Size (2015-2020)
9.2 Cancer Cachexia Key Players in Japan (2019-2020)
9.3 Japan Cancer Cachexia Market Size by Type (2015-2020)
9.4 Japan Cancer Cachexia Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Cachexia Market Size (2015-2020)
10.2 Cancer Cachexia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Cachexia Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Cachexia Market Size by Application (2015-2020)
11 India
11.1 India Cancer Cachexia Market Size (2015-2020)
11.2 Cancer Cachexia Key Players in India (2019-2020)
11.3 India Cancer Cachexia Market Size by Type (2015-2020)
11.4 India Cancer Cachexia Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Cachexia Market Size (2015-2020)
12.2 Cancer Cachexia Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Cachexia Market Size by Type (2015-2020)
12.4 Central & South America Cancer Cachexia Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Aeterna Zentaris
13.1.1 Aeterna Zentaris Company Details
13.1.2 Aeterna Zentaris Business Overview
13.1.3 Aeterna Zentaris Cancer Cachexia Introduction
13.1.4 Aeterna Zentaris Revenue in Cancer Cachexia Business (2015-2020))
13.1.5 Aeterna Zentaris Recent Development
13.2 Alder BioPharmaceuticals
13.2.1 Alder BioPharmaceuticals Company Details
13.2.2 Alder BioPharmaceuticals Business Overview
13.2.3 Alder BioPharmaceuticals Cancer Cachexia Introduction
13.2.4 Alder BioPharmaceuticals Revenue in Cancer Cachexia Business (2015-2020)
13.2.5 Alder BioPharmaceuticals Recent Development
13.3 Aphios
13.3.1 Aphios Company Details
13.3.2 Aphios Business Overview
13.3.3 Aphios Cancer Cachexia Introduction
13.3.4 Aphios Revenue in Cancer Cachexia Business (2015-2020)
13.3.5 Aphios Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Cancer Cachexia Introduction
13.4.4 Eli Lilly Revenue in Cancer Cachexia Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 GTx
13.5.1 GTx Company Details
13.5.2 GTx Business Overview
13.5.3 GTx Cancer Cachexia Introduction
13.5.4 GTx Revenue in Cancer Cachexia Business (2015-2020)
13.5.5 GTx Recent Development
13.6 Helsinn
13.6.1 Helsinn Company Details
13.6.2 Helsinn Business Overview
13.6.3 Helsinn Cancer Cachexia Introduction
13.6.4 Helsinn Revenue in Cancer Cachexia Business (2015-2020)
13.6.5 Helsinn Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Cancer Cachexia Introduction
13.7.4 Merck Revenue in Cancer Cachexia Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Cancer Cachexia Introduction
13.8.4 Novartis Revenue in Cancer Cachexia Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Details
13.9.2 Bristol-Myers Squibb Business Overview
13.9.3 Bristol-Myers Squibb Cancer Cachexia Introduction
13.9.4 Bristol-Myers Squibb Revenue in Cancer Cachexia Business (2015-2020)
13.9.5 Bristol-Myers Squibb Recent Development
13.10 XBiotech
13.10.1 XBiotech Company Details
13.10.2 XBiotech Business Overview
13.10.3 XBiotech Cancer Cachexia Introduction
13.10.4 XBiotech Revenue in Cancer Cachexia Business (2015-2020)
13.10.5 XBiotech Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cancer Cachexia Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Cachexia Revenue
Table 3. Ranking of Global Top Cancer Cachexia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Cachexia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Progestogens
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Combination therapies
Table 8. Global Cancer Cachexia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cancer Cachexia Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cancer Cachexia Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cancer Cachexia Market Share by Regions (2015-2020)
Table 12. Global Cancer Cachexia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cancer Cachexia Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cancer Cachexia Market Growth Strategy
Table 18. Main Points Interviewed from Key Cancer Cachexia Players
Table 19. Global Cancer Cachexia Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cancer Cachexia Market Share by Players (2015-2020)
Table 21. Global Top Cancer Cachexia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Cachexia as of 2019)
Table 22. Global Cancer Cachexia by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Cachexia Product Solution and Service
Table 25. Date of Enter into Cancer Cachexia Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Cachexia Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cancer Cachexia Market Size Share by Type (2015-2020)
Table 29. Global Cancer Cachexia Revenue Market Share by Type (2021-2026)
Table 30. Global Cancer Cachexia Market Size Share by Application (2015-2020)
Table 31. Global Cancer Cachexia Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cancer Cachexia Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cancer Cachexia Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cancer Cachexia Market Share (2019-2020)
Table 35. North America Cancer Cachexia Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cancer Cachexia Market Share by Type (2015-2020)
Table 37. North America Cancer Cachexia Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cancer Cachexia Market Share by Application (2015-2020)
Table 39. Europe Key Players Cancer Cachexia Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cancer Cachexia Market Share (2019-2020)
Table 41. Europe Cancer Cachexia Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cancer Cachexia Market Share by Type (2015-2020)
Table 43. Europe Cancer Cachexia Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cancer Cachexia Market Share by Application (2015-2020)
Table 45. China Key Players Cancer Cachexia Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cancer Cachexia Market Share (2019-2020)
Table 47. China Cancer Cachexia Market Size by Type (2015-2020) (Million US$)
Table 48. China Cancer Cachexia Market Share by Type (2015-2020)
Table 49. China Cancer Cachexia Market Size by Application (2015-2020) (Million US$)
Table 50. China Cancer Cachexia Market Share by Application (2015-2020)
Table 51. Japan Key Players Cancer Cachexia Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cancer Cachexia Market Share (2019-2020)
Table 53. Japan Cancer Cachexia Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cancer Cachexia Market Share by Type (2015-2020)
Table 55. Japan Cancer Cachexia Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cancer Cachexia Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cancer Cachexia Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cancer Cachexia Market Share (2019-2020)
Table 59. Southeast Asia Cancer Cachexia Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cancer Cachexia Market Share by Type (2015-2020)
Table 61. Southeast Asia Cancer Cachexia Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cancer Cachexia Market Share by Application (2015-2020)
Table 63. India Key Players Cancer Cachexia Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cancer Cachexia Market Share (2019-2020)
Table 65. India Cancer Cachexia Market Size by Type (2015-2020) (Million US$)
Table 66. India Cancer Cachexia Market Share by Type (2015-2020)
Table 67. India Cancer Cachexia Market Size by Application (2015-2020) (Million US$)
Table 68. India Cancer Cachexia Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cancer Cachexia Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cancer Cachexia Market Share (2019-2020)
Table 71. Central & South America Cancer Cachexia Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cancer Cachexia Market Share by Type (2015-2020)
Table 73. Central & South America Cancer Cachexia Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cancer Cachexia Market Share by Application (2015-2020)
Table 75. Aeterna Zentaris Company Details
Table 76. Aeterna Zentaris Business Overview
Table 77. Aeterna Zentaris Product
Table 78. Aeterna Zentaris Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 79. Aeterna Zentaris Recent Development
Table 80. Alder BioPharmaceuticals Company Details
Table 81. Alder BioPharmaceuticals Business Overview
Table 82. Alder BioPharmaceuticals Product
Table 83. Alder BioPharmaceuticals Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 84. Alder BioPharmaceuticals Recent Development
Table 85. Aphios Company Details
Table 86. Aphios Business Overview
Table 87. Aphios Product
Table 88. Aphios Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 89. Aphios Recent Development
Table 90. Eli Lilly Company Details
Table 91. Eli Lilly Business Overview
Table 92. Eli Lilly Product
Table 93. Eli Lilly Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 94. Eli Lilly Recent Development
Table 95. GTx Company Details
Table 96. GTx Business Overview
Table 97. GTx Product
Table 98. GTx Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 99. GTx Recent Development
Table 100. Helsinn Company Details
Table 101. Helsinn Business Overview
Table 102. Helsinn Product
Table 103. Helsinn Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 104. Helsinn Recent Development
Table 105. Merck Company Details
Table 106. Merck Business Overview
Table 107. Merck Product
Table 108. Merck Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 109. Merck Recent Development
Table 110. Novartis Business Overview
Table 111. Novartis Product
Table 112. Novartis Company Details
Table 113. Novartis Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 114. Novartis Recent Development
Table 115. Bristol-Myers Squibb Company Details
Table 116. Bristol-Myers Squibb Business Overview
Table 117. Bristol-Myers Squibb Product
Table 118. Bristol-Myers Squibb Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 119. Bristol-Myers Squibb Recent Development
Table 120. XBiotech Company Details
Table 121. XBiotech Business Overview
Table 122. XBiotech Product
Table 123. XBiotech Revenue in Cancer Cachexia Business (2015-2020) (Million US$)
Table 124. XBiotech Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Cachexia Market Share by Type: 2020 VS 2026
Figure 2. Progestogens Features
Figure 3. Corticosteroids Features
Figure 4. Combination therapies Features
Figure 5. Global Cancer Cachexia Market Share by Application: 2020 VS 2026
Figure 6. Hospital Stores Case Studies
Figure 7. Retails Pharmacy Store Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Cancer Cachexia Report Years Considered
Figure 10. Global Cancer Cachexia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Cancer Cachexia Market Share by Regions: 2020 VS 2026
Figure 12. Global Cancer Cachexia Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Cancer Cachexia Market Share by Players in 2019
Figure 15. Global Top Cancer Cachexia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Cachexia as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Cancer Cachexia Revenue in 2019
Figure 17. North America Cancer Cachexia Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Cancer Cachexia Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Cancer Cachexia Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Cancer Cachexia Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Cancer Cachexia Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Cancer Cachexia Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Cancer Cachexia Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
癌性食欲不振-悪液質症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Cancer Anorexia-Cachexia Syndrome Drug Market The global Cancer Anorexia-Cachexia Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Anorexia-Cachexia Syndrome Dru…- がん治療の世界市場（～2026年） Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer,…
- 精密がん治療の世界市場（～2026年） Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormali…
- 子宮頸がん治療法・診断の世界市場（～2026年） Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer. The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually ac…
- 肺癌の世界市場（～2026年） Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…